Positive modulators of nicotinic acetylcholine receptors

Details for Australian Patent Application No. 2004237130 (hide)

Owner AstraZeneca AB

Inventors Murphy, Megan; Becker, Christopher; Simpson, Thomas R; Phillips, Eifion; Michne, William F; Comstock, Jeanne; Rosamond, James D

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004237130

PCT Pub. Number WO2004/098600

Priority 0301320-8 06.05.03 SE

Filing date 4 May 2004

Wipo publication date 18 November 2004

International Classifications

A61K 031/47 - Quinolines

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61P 025/28 Drugs for disorders of the nervous system

A61P 025/18 Drugs for disorders of the nervous system

A61P 025/26 Drugs for disorders of the nervous system

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/098600 Priority application(s): WO2004/098600

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237131-Particulate materials

2004237127-Combination of a glycine/nmda antagonist and a tachykinin NK-1 receptor antagonist for use in the treatment of neurodegeneration